BOXED WARNING Opioid addiction/abuse/misuse risk (assess before and during); life-threatening respiratory depression (esp. at initiation/dose increase); accidental ingestion of one dose can be fatal in children; concomitant benzodiazepines/CNS depressants → profound sedation, respiratory depression, coma, death; prolonged in-utero exposure → neonatal opioid withdrawal syndrome; CYP3A4 inhibitor use (or inducer discontinuation) can raise hydrocodone levels → fatal respiratory depression; acetaminophen hepatotoxicity — acute liver failure, mostly at >4,000 mg/day APAP or multiple APAP products; opioid REMS.
FDA dosing
Population
Start
Target
Max
Pain severe enough to require an opioid, alternatives inadequate (5/325 mg)
Adults
1–2 tabs q4–6h PRN
Lowest dose achieving adequate analgesia
8 tabs/day
Same (7.5/325 mg or 10/325 mg)
Adults
1 tab q4–6h PRN
Lowest dose achieving adequate analgesia
6 tabs/day
Renal Severe renal disease: follow therapy with serial renal function tests (label gives no dose adjustment)
Hepatic Severe hepatic disease: follow therapy with serial liver function tests (label gives no dose adjustment); APAP hepatotoxicity risk >4,000 mg/day
Total daily acetaminophen from ALL sources — hepatotoxicity mostly at >4,000 mg/day APAP
Instructions
Use lowest effective dose for shortest duration; many acute pain conditions need no more than a few days
Converting from other opioids: underestimate the 24-h dose (conservative conversion)
Do not abruptly stop in physically dependent patients: taper ≤10–25% of total daily dose every 2–4 weeks; pause or slow taper if withdrawal emerges
Discuss access to an opioid overdose reversal agent (naloxone/nalmefene) with all patients
Store securely out of reach of children; dispose of unused tablets promptly (flush if no take-back available)
Available strengths
tab 5/325, 7.5/325, 10/325 mg
Contraindications
Significant respiratory depression
Acute or severe bronchial asthma in unmonitored setting or without resuscitative equipment
Known or suspected GI obstruction, including paralytic ileus
Cautions
Life-threatening respiratory depression — greatest risk at initiation/dose increase; elderly, cachectic, debilitated, and chronic pulmonary disease patients at higher risk
Concomitant benzodiazepines/CNS depressants/alcohol: reserve for inadequate alternatives
Adrenal insufficiency (usually >1 month of use)
Severe hypotension incl. orthostatic; caution with circulatory shock
Serotonin syndrome with concomitant serotonergic drugs
Opioid-induced hyperalgesia/allodynia
May impair driving/machinery operation
Adverse reactions
Most frequent: light-headedness, dizziness, sedation, nausea, vomiting
Pregnancy Prolonged use during pregnancy → neonatal opioid withdrawal syndrome (life-threatening if not recognized/treated; ensure neonatology management at delivery); can cause fetal harm
Lactation Advise nursing mothers to watch infant for increased sleepiness, breathing difficulty, or limpness and seek immediate care
Cost
Vicodin / Norco
What pharmacies pay · NADAC 9/30/26
Strength
#/mo
generic $/unit
CostPlus
5/325 mg
tab
per unit
$0.14/ea
not offered
7.5/325 mg
tab
per unit
$0.14/ea
not offered
10/325 mg
tab
per unit
$0.15/ea
not offered
Clinical profile
Therapeutic safety burden3 / 4
Overdose danger4 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk3 / 4
Defining liabilityRespiratory depression, dependence and acetaminophen liver injury
Part D rank #26.
Self-check
Which component accounts for Vicodin / Norco’s boxed hepatotoxicity? Acetaminophen.
Which respiratory harm is boxed for Vicodin / Norco? Life-threatening respiratory depression.